Evidence map›Paper›PMID 28073917›Full record

ArticleEMBO reports2017

The E3 ubiquitin ligase RNF114 and TAB1 degradation are required for maternal-to-zygotic transition.

Ye Yang, Cheng Zhou, Ying Wang, Weixiao Liu, Chao Liu, Liying Wang, Yujiao Liu, Yongliang Shang, Mingrui Li, Shuai Zhou and 5 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. PABPN1L is required for maternal mRNA degradation after meiosis resumption.The Journal of reproduction and development · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. PROTACs in gastrointestinal cancers.Molecular therapy oncolytics · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Ye YangState Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, China.
Cheng ZhouState Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, China.
Ying WangState Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, China.
Weixiao LiuState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, the Chinese Academy of Science, Beijing, China.
Chao LiuState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, the Chinese Academy of Science, Beijing, China.
Liying WangState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, the Chinese Academy of Science, Beijing, China.
Yujiao LiuState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, the Chinese Academy of Science, Beijing, China.
Yongliang ShangState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, the Chinese Academy of Science, Beijing, China.
Mingrui LiState Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, China.
Shuai ZhouState Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, China.
Yuanting WangState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, the Chinese Academy of Science, Beijing, China.
Wentao ZengAnimal Core Facility, Nanjing Medical University, Nanjing, China.
Jianli ZhouAnimal Core Facility, Nanjing Medical University, Nanjing, China.
Ran HuoState Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, China huoran@njmu.edu.cn leways@ioz.ac.cn.ORCID 0000-0001-5166-127X
Wei LiState Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, the Chinese Academy of Science, Beijing, China huoran@njmu.edu.cn leways@ioz.ac.cn.
Institute of Zoology · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The functional role of the ubiquitin-proteasome pathway during maternal-to-zygotic transition (MZT) remains to be elucidated. Here we show that the E3 ubiquitin ligase, Rnf114, is highly expressed in mouse oocytes and that knockdown of Rnf114 inhibits development beyond the two-cell stage. To study the underlying mechanism, we identify its candidate substrates using a 9,000-protein microarray and validate them using an in vitro ubiquitination system. We show that five substrates could be degraded by RNF114-mediated ubiquitination, including TAB1. Furthermore, the degradation of TAB1 in mouse early embryos is required for MZT, most likely because it activates the NF-κB pathway. Taken together, our study uncovers that RNF114-mediated ubiquitination and degradation of TAB1 activate the NF-κB pathway during MZT, and thus directly link maternal clearance to early embryo development.

Indexed as

Maternal InheritanceAdaptor Proteins, Signal TransducingAnimalsCluster AnalysisEmbryonic DevelopmentFemaleGene Expression ProfilingGene Expression Regulation, DevelopmentalGene Knockdown TechniquesMiceNF-kappa BOocytesPolyubiquitinProteolysisSignal TransductionSubstrate SpecificityAdaptor Proteins, Signal TransducingNF-kappa BPolyubiquitinTab1 protein, mouseUbiquitin-Protein Ligasesmaternal‐to‐zygotic transitionNF‐κB pathwayRNF114TAB1two‐cell‐stage arrest

Identifiers

PMID28073917
PMCPMC5286393
OpenAlexW2569472949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.